Literature DB >> 19162280

Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.

Istvan Pirko1, Aaron J Johnson, Anne K Lohrey, Yi Chen, Jun Ying.   

Abstract

Advanced MRI studies demonstrated several diffuse non-lesional features in multiple sclerosis, including changes detectable in gray matter areas. Standard T2 weighted MRI scans of deep gray matter structures, including the thalamus, caudate, putamen, dentate nuclei often demonstrate hypointensity. T2 hypointensity has been shown to correlate with cognitive, neuropsychiatric and motor dysfunction. The exact pathogenesis of this MRI phenomenon remains unknown. In this manuscript, we demonstrate the first known MS animal model of deep gray matter T2 hypointensity. In TMEV infected SJL/J mice, gradual development of thalamic T2 hypointensity was noted over the disease course. Quantitative analysis of the hypointensity demonstrated a strong correlation between the degree of T2 hypointensity and rotarod detectable disability. We propose that this model will allow mechanistic studies investigating the pathogenesis and significance of deep gray matter T2 hypointensity in MS.

Entities:  

Mesh:

Year:  2009        PMID: 19162280      PMCID: PMC2723804          DOI: 10.1016/j.jns.2008.12.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  38 in total

Review 1.  3-D visualization in biomedical applications.

Authors:  R A Robb
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

2.  The biomedical imaging resource at Mayo Clinic.

Authors:  R A Robb
Journal:  IEEE Trans Med Imaging       Date:  2001-09       Impact factor: 10.048

Review 3.  Multiple sclerosis.

Authors:  J H Noseworthy; C Lucchinetti; M Rodriguez; B G Weinshenker
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 4.  Theiler's virus infection of the mouse, or: of the importance of studying animal models.

Authors:  Michel Brahic
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

5.  Thalamic neurodegeneration in multiple sclerosis.

Authors:  Alberto Cifelli; Marzena Arridge; Peter Jezzard; Margaret M Esiri; Jacqueline Palace; Paul M Matthews
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

6.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.

Authors:  Rohit Bakshi; Ralph H B Benedict; Robert A Bermel; Shelton D Caruthers; Srinivas R Puli; Christopher W Tjoa; Andrew J Fabiano; Lawrence Jacobs
Journal:  Arch Neurol       Date:  2002-01

7.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

Authors:  R Bakshi; J Dmochowski; Z A Shaikh; L Jacobs
Journal:  J Neurol Sci       Date:  2001-03-15       Impact factor: 3.181

8.  Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.

Authors:  K M Mitchell; A L Dotson; K M Cool; A Chakrabarty; S H Benedict; S M LeVine
Journal:  Mult Scler       Date:  2007-11       Impact factor: 6.312

9.  Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model.

Authors:  Istvan Pirko; Tifany K Nolan; Scott K Holland; Aaron J Johnson
Journal:  Radiology       Date:  2008-03       Impact factor: 11.105

10.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Authors:  M Wylezinska; A Cifelli; P Jezzard; J Palace; M Alecci; P M Matthews
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  14 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

Review 3.  MRI in rodent models of brain disorders.

Authors:  Aleksandar Denic; Slobodan I Macura; Prasanna Mishra; Jeffrey D Gamez; Moses Rodriguez; Istvan Pirko
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

4.  Unilateral hemispherectomy at adulthood asymmetrically affects motor performance of male Swiss mice.

Authors:  Danielle Paes-Branco; Yael Abreu-Villaça; Alex C Manhães; Cláudio C Filgueiras
Journal:  Exp Brain Res       Date:  2012-02-25       Impact factor: 1.972

5.  Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis.

Authors:  M Mateo Paz Soldán; Mekala R Raman; Jeffrey D Gamez; Anne K Lohrey; Yi Chen; Istvan Pirko; Aaron J Johnson
Journal:  J Neuroimaging       Date:  2015-04-20       Impact factor: 2.486

6.  Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis.

Authors:  I Pirko; A J Johnson; Yi Chen; D M Lindquist; A K Lohrey; J Ying; R Scott Dunn
Journal:  Neuroimage       Date:  2010-09-15       Impact factor: 6.556

Review 7.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

8.  Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis.

Authors:  Francesca Gilli; Darlene B Royce; Andrew R Pachner
Journal:  J Vis Exp       Date:  2016-11-14       Impact factor: 1.355

Review 9.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

10.  CMV infection attenuates the disease course in a murine model of multiple sclerosis.

Authors:  Istvan Pirko; Rhonda Cardin; Yi Chen; Anne K Lohrey; Diana M Lindquist; R Scott Dunn; Robert Zivadinov; Aaron J Johnson
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.